The Vi Capsular Polysaccharide of Salmonella Typhi Promotes Macrophage Phagocytosis by Binding the Human C-Type Lectin DC-SIGN

Salmonella enterica subspecies enterica serovar Typhi is the causative agent of typhoid fever. The recent emergence of S. Typhi strains which are resistant to antibiotic therapy highlights the importance of vaccination in managing typhoid fever. ABSTRACT Capsular polysaccharides are common virulence factors of extracellular, but not intracellular bacterial pathogens, due to the antiphagocytic properties of these surface structures. It is therefore paradoxical that Salmonella enterica subspecies enterica serovar Typhi, an intracellular pathogen, synthesizes a virulence-associated (Vi) capsule, which exhibits antiphagocytic properties. Here, we show that the Vi capsular polysaccharide has different functions when S. Typhi interacts with distinct subsets of host phagocytes. The Vi capsular polysaccharide allowed S. Typhi to selectively evade phagocytosis by human neutrophils while promoting human macrophage phagocytosis. A screen of C-type lectin receptors identified human DC-SIGN as the receptor involved in macrophage binding and phagocytosis of capsulated S. Typhi. Consistent with the anti-inflammatory activity of DC-SIGN, purified Vi capsular polysaccharide reduced inflammatory responses in macrophages. These data suggest that binding of the human C-type lectin receptor DC-SIGN by the Vi capsular polysaccharide contributes to the pathogenesis of typhoid fever. IMPORTANCE Salmonella enterica subspecies enterica serovar Typhi is the causative agent of typhoid fever. The recent emergence of S. Typhi strains which are resistant to antibiotic therapy highlights the importance of vaccination in managing typhoid fever. The virulence-associated (Vi) capsular polysaccharide is an effective vaccine against typhoid fever, but the role the capsule plays during pathogenesis remains incompletely understood. Here, we identify the human C-type lectin receptor DC-SIGN as the receptor for the Vi capsular polysaccharide. Binding of capsulated S. Typhi to DC-SIGN resulted in phagocytosis of the pathogen by macrophages and induction of an anti-inflammatory cytokine response. Thus, the interaction of the Vi capsular polysaccharide with human DC-SIGN contributes to the pathogenesis of typhoid fever and should be further investigated in the context of vaccine development.

[1]  N. V. van Sorge,et al.  C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens , 2020, Frontiers in Cellular and Infection Microbiology.

[2]  M. Skurnik,et al.  Salmonella enterica Serovar Typhimurium Interacts with CD209 Receptors To Promote Host Dissemination and Infection , 2019, Infection and Immunity.

[3]  B. Cobb,et al.  Purification of Capsular Polysaccharide Complex from Gram-Negative Bacteria. , 2019, Methods in molecular biology.

[4]  Denise N. Bronner,et al.  Typhoidal Salmonella serovars: ecological opportunity and the evolution of a new pathovar , 2018, FEMS microbiology reviews.

[5]  A. Bäumler,et al.  Mechanisms to Evade the Phagocyte Respiratory Burst Arose by Convergent Evolution in Typhoidal Salmonella Serovars , 2018, Cell reports.

[6]  C. Josenhans,et al.  C-Type Lectin Receptor (CLR)–Fc Fusion Proteins As Tools to Screen for Novel CLR/Bacteria Interactions: An Exemplary Study on Preselected Campylobacter jejuni Isolates , 2018, Front. Immunol..

[7]  Sky W. Brubaker,et al.  Complement pathway amplifies caspase-11–dependent cell death and endotoxin-induced sepsis severity , 2016, The Journal of experimental medicine.

[8]  C. Whitfield,et al.  Unique lipid anchor attaches Vi antigen capsule to the surface of Salmonella enterica serovar Typhi , 2016, Proceedings of the National Academy of Sciences.

[9]  G. Dougan,et al.  Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen , 2016, PloS one.

[10]  S. Winter,et al.  The Flagellar Regulator TviA Reduces Pyroptosis by Salmonella enterica Serovar Typhi , 2015, Infection and Immunity.

[11]  V. Heinrich,et al.  The Vi Capsular Polysaccharide Enables Salmonella enterica Serovar Typhi to Evade Microbe-Guided Neutrophil Chemotaxis , 2014, PLoS pathogens.

[12]  S. Winter,et al.  Salmonella enterica Serovar Typhi Conceals the Invasion-Associated Type Three Secretion System from the Innate Immune System by Gene Regulation , 2014, PLoS pathogens.

[13]  S. Atif,et al.  Salmonella enterica Serovar Typhi Impairs CD4 T Cell Responses by Reducing Antigen Availability , 2014, Infection and Immunity.

[14]  Peter H Seeberger,et al.  A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Gordon D. Brown,et al.  Signalling C‐Type lectin receptors, microbial recognition and immunity , 2014, Cellular microbiology.

[16]  G. Dougan,et al.  Molecular Characterization of the viaB Locus Encoding the Biosynthetic Machinery for Vi Capsule Formation in Salmonella Typhi , 2012, PloS one.

[17]  A. Bäumler,et al.  How To Become a Top Model: Impact of Animal Experimentation on Human Salmonella Disease Research , 2011, Infection and Immunity.

[18]  S. Winter,et al.  The Vi Capsular Polysaccharide Prevents Complement Receptor 3-Mediated Clearance of Salmonella enterica Serotype Typhi , 2010, Infection and Immunity.

[19]  Jeremy S. Brown,et al.  The Streptococcuspneumoniae Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms , 2009, Infection and Immunity.

[20]  S. Winter,et al.  The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity , 2009, Molecular microbiology.

[21]  S. Gringhuis,et al.  Signalling through C-type lectin receptors: shaping immune responses , 2009, Nature Reviews Immunology.

[22]  A. Azad,et al.  Mutation in the DC‐SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose‐containing ligands by human myeloid cells , 2008, Journal of leukocyte biology.

[23]  M. Carrington,et al.  The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates , 2008, Genes and Immunity.

[24]  S. Winter,et al.  The Salmonella enterica serotype Typhi regulator TviA reduces interleukin‐8 production in intestinal epithelial cells by repressing flagellin secretion , 2007, Cellular microbiology.

[25]  Y. Kooyk,et al.  C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB , 2007 .

[26]  S. Gringhuis,et al.  C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. , 2007, Immunity.

[27]  K. Sanderson,et al.  Role of N-Acetylglucosamine within Core Lipopolysaccharide of Several Species of Gram-Negative Bacteria in Targeting the DC-SIGN (CD209)1 , 2006, The Journal of Immunology.

[28]  B. Cookson,et al.  In vivo, fliC expression by Salmonella enterica serovar Typhimurium is heterogeneous, regulated by ClpX, and anatomically restricted , 2006, Molecular microbiology.

[29]  B. Ferry,et al.  Development of an anti‐Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors , 2004, Clinical and experimental immunology.

[30]  C. Landrigan,et al.  Outbreaks of typhoid fever in the United States, 1960-99. , 2003, Epidemiology and infection.

[31]  Alessandra Cambi,et al.  The C‐type lectin DC‐SIGN (CD209) is an antigen‐uptake receptor for Candida albicans on dendritic cells , 2003, European journal of immunology.

[32]  J. Trowsdale,et al.  Human atherosclerotic plaques express DC‐SIGN, a novel protein found on dendritic cells and macrophages , 2002, The Journal of pathology.

[33]  M. Frosch,et al.  Lipooligosaccharide and Polysaccharide Capsule: Virulence Factors of Neisseria meningitidis That Determine Meningococcal Interaction with Human Dendritic Cells , 2002, Infection and Immunity.

[34]  Kim Rutherford,et al.  Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18 , 2001, Nature.

[35]  K. Drickamer.  C-type lectin-like domains. , 1999, Current opinion in structural biology.

[36]  F. Rosen,et al.  Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. , 1997, Journal of immunology.

[37]  M. Popoff,et al.  Role of the viaB locus in synthesis, transport and expression of Salmonella typhi Vi antigen. , 1995, Microbiology.

[38]  P. Domenico,et al.  Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae , 1994, Infection and immunity.

[39]  B. Shin,et al.  Bone marrow pathology of culture proven typhoid fever. , 1994, Journal of Korean medical science.

[40]  S. Palmer,et al.  Incubation period, severity of disease, and infecting dose: evidence from a Salmonella outbreak. , 1992, American journal of epidemiology.

[41]  G. Noel,et al.  Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains. , 1992, The Journal of infectious diseases.

[42]  J. Goldberg,et al.  Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Moxon,et al.  The role of bacterial polysaccharide capsules as virulence factors. , 1990, Current topics in microbiology and immunology.

[44]  R. Steigbigel,et al.  Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro. , 1986, The Journal of laboratory and clinical medicine.

[45]  P. Densen,et al.  Diminished neutrophil oxidative metabolism after phagocytosis of virulent Salmonella typhi , 1981, Infection and immunity.

[46]  B. Wilkinson,et al.  Staphylococcus aureus cell surface: capsule as a barrier to bacteriophage adsorption , 1979, Infection and immunity.

[47]  V. Nassar,et al.  Enteric fever: a clinicopathologic study of 104 cases. , 1978, The American journal of gastroenterology.

[48]  L. Baron,et al.  Genetic Basis of Vi Antigen Expression in Salmonella paratyphi C , 1977, Journal of bacteriology.

[49]  R. Hornick,et al.  Lack of Enhanced Oxygen Consumption by Polymorphonuclear Leukocytes on Phagocytosis of Virulent Salmonella typhi , 1972, Science.

[50]  K. Heyns,et al.  Strukturaufklärung des vi-antigens aus Citrobacter freundii (E. coli) 5396/38 , 1967 .

[51]  R. Pitt,et al.  A NEW ANTIGEN OF B. TYPHOSUS: ITS RELATION TO VIRULENCE AND TO ACTIVE AND PASSIVE IMMUNISATION , 1934 .

[52]  The Outbreaks of Typhoid Fever , 1897, British medical journal.